Research On The Evaluation Of The Intangible Asset’s Contribution To Pharmaceutical Enterprise Value For Company C

As the progress and development of world, the operation mode of human society is facing the shift from labor-intensive industries to technology-intensive industries. Intangible assets are more and more important to create enterprise value. Intangible assets have become the core power for high-tech companies` development, how to effectively manage the intangible assets is the key to improve market competiveness. In order to create self-advantages and expand enterprise scale in the completive market, more and more companies start to focus on researching and managing intangible assets. For pharmaceutical manufacturing enterprises, in tangible assets have features like high input、high return and high risk. Therefore, study on intangible assets` contribution to enterprise value is meaningful.This paper has three parts, the first part summarizes the domestic and foreign researches on the contribution of intangible assets to the enterprise value; define the meaning and classification of intangible assets; describe the evaluation method of intangible assets contribution to enterprise value. In the second part, 50 pharmaceutical companies are randomly selected from Chinese stock market, this part analyze the disclosure data of intangible assets based the accounting perspective of intangible assets` classification. After using regression analysis to analyze these data, the results indicate the technical intangible assets have greater contribution to enterprise value; the rights have little contribution to enterprise value. The last part analyze pharmaceutical company C`s intangible assets management based on theoretical research and data analysis in the previous two parts. Many types of intangible assets are not disclosed in the financial statements, due to the limitation of Chinese accounting standards. Thus we use business and accounting perspectives of intangible assets` classification as the main idea to analyze and evaluate company C`s technological 、 human reassures and marketing intangible assets management, and then find out the feasible improvement methods.